Ahead of this week’s presentation of the European Commission’s Action Plan on how to implement the 2017 European Pillar of Social Rights, the Socialists and Democrats in the European Parliament issued a strong call for making social rights a reality for all Europeans by introducing binding targets.
Members of the S&D Group in the AIDA (Artificial Intelligence in the Digital Age) special committee will host this week a debate on Valuing Labour in the age of AI. With a focus on how Artificial Intelligence can complement human labour in the workplace and in general, members will discuss with specialists what are the current challenges and best practices to be implemented.
The generic medicines sector provides most prescription medicines in Europe, helping patients and healthcare professionals manage some of the most challenging health conditions, virtually across all therapy areas. Moreover, the COVID-19 pandemic showcased the essential role that off-patent medicines play in a large public health crisis.
As the interinstitutional negotiations are about to resume on the coordination of social security systems with the new mandate obtained by the Portuguese Presidency, “FIEC is opposed to any form of temporary exemption to the prior notification of the A1 form for the construction industry” warns FIEC Vice-President Joël Schons.
Brussels, 26 February 2021 - The Ecodesign and Energy Labelling Regulations adopted in December 2019 have been revised. An updated version has been published in the Official Journal of the EU today and enters into force in 3 days. LightingEurope members are disappointed that important changes requested by our association have not been included. Most of the new Ecodesign and the Energy Labelling rules start to apply on 1 September 2021.
In light of the public hearing entitled ‘How to increase the capacity of COVID-19 vaccine production and improve delivery’, jointly hosted by the environment, public health and food safety committee (ENVI) and the industry, research and energy committee (ITRE) in the European Parliament, the Socialists and Democrats Group demands all pharmaceutical companies to increase the production of vaccines, and look at future challenges with new variants and strains.
Reacting to the decision of the Competitiveness Council, to start negotiations with the European Parliament on public country-by-country reporting (pCBCR), the Socialists and Democrats Group set out their priorities for the file.
Ibán García del Blanco, S&D MEP and Parliament negotiator on the public CBCR file, said: